| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.082 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |